Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-000901-21Phase 4Active
Phase 4, randomised trial in burn injury and partial-thickness burn comparing Flaminal with Flammazine (2 arms). Primary endpoint: Time to complete re-epithelialization. Started Jun 2013; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-000901-21.